EGFR and familial pancreatic carcinoma: Gupta and colleagues constructed a Gem encapsulated nanoplatform against pancreatic cancer through covalent binding to EGFR antibodies [37], presenting higher cytotoxicity of the designed nanoplatform for EGFR-overexpressing pancreatic cell lines.